Literature DB >> 4565920

[Biochemistry of depression].

N Matussek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4565920     DOI: 10.1007/bf01245319

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  44 in total

1.  Cerebrospinal fluid levels of MHPG in affective disorders.

Authors:  S Wilk; B Shopsin; S Gershon; M Suhl
Journal:  Nature       Date:  1972-02-25       Impact factor: 49.962

2.  Effect of psychotropic drugs on tryptophan concentration in the rat brain.

Authors:  A Tagliamonte; P Tagliamonte; J Perez-Cruet; S Stern; G L Gessa
Journal:  J Pharmacol Exp Ther       Date:  1971-06       Impact factor: 4.030

3.  Tryptophan in the treatment of depression.

Authors:  A Coppen; D M Shaw; B Herzberg; R Maggs
Journal:  Lancet       Date:  1967-12-02       Impact factor: 79.321

4.  Sequential comparison of L-tryptophan with E.C.T. in severe depression.

Authors:  B J Carroll; R M Mowbray; B Davies
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

5.  Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

Authors:  H R Bourne; W E Bunney; R W Colburn; J M Davis; J N Davis; D M Shaw; A J Coppen
Journal:  Lancet       Date:  1968-10-12       Impact factor: 79.321

6.  Abnormalities of indoleamines in affective disorders.

Authors:  A Coppen; A J Prange; P C Whybrow; R Noguera
Journal:  Arch Gen Psychiatry       Date:  1972-05

7.  Inhibition of rat brain tryptophan hydroxylase by 6-halotryptophans.

Authors:  E G McGeer; D A Peters; P L McGeer
Journal:  Life Sci       Date:  1968-06-15       Impact factor: 5.037

8.  [Therapy of endogenous depressions using sleep deprivation. Practical and theoretical consequences].

Authors:  B Pflug; R Tölle
Journal:  Nervenarzt       Date:  1971-03       Impact factor: 1.214

9.  Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin.

Authors:  E Jéquier; W Lovenberg; A Sjoerdsma
Journal:  Mol Pharmacol       Date:  1967-05       Impact factor: 4.436

10.  CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION.

Authors:  G L KLERMAN; J J SCHILDKRAUT; L L HASENBUSH; M GREENBLATT; D G FRIEND
Journal:  J Psychiatr Res       Date:  1963-12       Impact factor: 4.791

View more
  4 in total

1.  The tyrosine-tryptophan-diagram in a longtime study with depressed patients.

Authors:  P Riederer; W Birkmayer; E Neumayer
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

2.  [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].

Authors:  W Rackensperger; W Fritsch; D Schwarz; K H Stutte; D Zerssen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-10-28

3.  Pathophysiology of depression and mechanisms of treatment.

Authors:  Bondy Brigitta
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

Review 4.  Circadian rhythm hypotheses of mixed features, antidepressant treatment resistance, and manic switching in bipolar disorder.

Authors:  Heon-Jeong Lee; Gi-Hoon Son; Dongho Geum
Journal:  Psychiatry Investig       Date:  2013-09-16       Impact factor: 2.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.